Wall Street experts say to keep buying Nuvation Bio, but they lowered their price targets to $17 and $13.

Nov 7, 2026, 10:17 AM ETOpinionRead the original at moomoo.com

Neutral

Four firms kept Buy ratings, but RBC and B. Riley cut targets; Wedbush and H.C.

NUVB · Nuvation Bio Inc.

AI read · Neutral

The AI's read

The ratings still show analyst support, but the target cuts point the other way. The other 2 firms kept their targets, and no company results were reported, so the story does not show a change in Nuvation Bio's business outlook.

Get alerts for NUVB

Follow Nuvation Bio Inc. (NUVB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NUVB

Free on the App Store and Google Play, or on the web.